找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biological Modulation of Solid Tumours by Interferons; Karl Pummer Conference proceedings 1994 Springer-Verlag Berlin Heidelberg 1994 Biol

[復(fù)制鏈接]
樓主: vitamin-D
31#
發(fā)表于 2025-3-26 23:35:24 | 只看該作者
Head and Neck Cancer,Head and neck cancer accounts for approximately 7% of all incident malignant neoplasms worldwide, and tumours of the mouth and pharynx alone represent the fourth most frequent malignancy in males [1].
32#
發(fā)表于 2025-3-27 04:03:39 | 只看該作者
Introduction,an confer resistance to attack by a wide range of viruses in a species-specific way. As soon as their importance in the regulation of immune responses as well as their involvement in the control of cell growth and differentiation had been recognised, the possibility of growth inhibition in cancer wa
33#
發(fā)表于 2025-3-27 08:55:49 | 只看該作者
34#
發(fā)表于 2025-3-27 11:11:29 | 只看該作者
Biomodulation of 5-Fluorouracil by Interferon-Alpha,offers little benefit as a single agent. Response rates in colon cancer, for example, range from 7% to 25%. When patients do achieve an objective response, the duration is generally short, and complete responses are uncommon.
35#
發(fā)表于 2025-3-27 13:36:11 | 只看該作者
36#
發(fā)表于 2025-3-27 20:57:32 | 只看該作者
Renal Cell Carcinoma,0 months with less than 10% of patients surviving for 2 years [1]. This poor prognosis depends on the fact that conventional therapy is ineffective, with an objective response rate of less than 20% for hormonal and chemotherapeutic agents given either alone or in combination [2]. These disappointing
37#
發(fā)表于 2025-3-28 00:50:01 | 只看該作者
Prostate Cancer,the United States and 34,000 prostatic cancer deaths occurred [1]. At the time of presentation, more than 50% of newly diagnosed patients either have locally advanced or metastatic disease. It is also widely recognised, however, that the prevalence of prostatic cancer found at autopsy largely surpas
38#
發(fā)表于 2025-3-28 02:28:20 | 只看該作者
9樓
39#
發(fā)表于 2025-3-28 07:24:21 | 只看該作者
9樓
40#
發(fā)表于 2025-3-28 10:50:00 | 只看該作者
9樓
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-17 18:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
两当县| 嘉义市| 阿拉善右旗| 上蔡县| 田阳县| 郑州市| 自治县| 蒲江县| 旬邑县| 吉水县| 南通市| 景宁| 芜湖市| 河津市| 潮安县| 长治市| 宜川县| 乌兰察布市| 嘉峪关市| 临泉县| 敦煌市| 黑山县| 江北区| 梅河口市| 密云县| 青阳县| 通州市| 蚌埠市| 新沂市| 泌阳县| 资溪县| 凤凰县| 沙湾县| 英吉沙县| 永济市| 皮山县| 温泉县| 班玛县| 会宁县| 凉城县| 抚松县|